Ubs Group Ag Chembio Diagnostics, Inc. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$0.25 - $0.45 $4,670 - $8,406
18,681 New
18,681 $8,000
Q1 2022

May 16, 2022
SELL
$0.66 - $1.23 $6,794 - $12,661
-10,294 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$1.09 - $2.55 $11,220 - $26,249
10,294 New
10,294 $12,000
Q3 2021

Nov 15, 2021
SELL
$2.06 - $5.34 $6,056 - $15,699
-2,940 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$2.88 - $5.64 $11,157 - $21,849
-3,874 Reduced 56.85%
2,940 $9,000
Q1 2021

May 12, 2021
BUY
$3.4 - $7.97 $6,174 - $14,473
1,816 Added 36.33%
6,814 $23,000
Q4 2020

Feb 11, 2021
BUY
$4.11 - $7.51 $16,431 - $30,024
3,998 Added 399.8%
4,998 $24,000
Q3 2020

Nov 12, 2020
SELL
$3.28 - $5.93 $23,297 - $42,120
-7,103 Reduced 87.66%
1,000 $5,000
Q2 2020

Jul 31, 2020
SELL
$3.18 - $15.54 $22,069 - $107,847
-6,940 Reduced 46.13%
8,103 $27,000
Q1 2020

May 01, 2020
SELL
$2.36 - $5.6 $27,779 - $65,917
-11,771 Reduced 43.9%
15,043 $78,000
Q4 2019

Feb 14, 2020
SELL
$3.94 - $5.76 $311 - $455
-79 Reduced 0.29%
26,814 $122,000
Q3 2019

Nov 14, 2019
BUY
$4.84 - $7.25 $1,316 - $1,972
272 Added 1.02%
26,893 $165,000
Q2 2019

Aug 14, 2019
BUY
$5.56 - $7.85 $14,572 - $20,574
2,621 Added 10.92%
26,621 $162,000
Q1 2019

May 14, 2019
BUY
$5.32 - $7.18 $105,548 - $142,451
19,840 Added 476.92%
24,000 $133,000
Q4 2018

Feb 14, 2019
BUY
$4.95 - $10.5 $3,366 - $7,140
680 Added 19.54%
4,160 $24,000
Q3 2018

Nov 14, 2018
BUY
$9.2 - $11.5 $8,224 - $10,281
894 Added 34.57%
3,480 $36,000
Q2 2018

Aug 14, 2018
BUY
$7.8 - $11.1 $2,230 - $3,174
286 Added 12.43%
2,586 $29,000
Q1 2018

May 15, 2018
SELL
$7.05 - $9.0 $4,779 - $6,102
-678 Reduced 22.77%
2,300 $18,000
Q4 2017

Feb 14, 2018
SELL
$5.95 - $8.35 $50,467 - $70,824
-8,482 Reduced 74.01%
2,978 $25,000
Q3 2017

Nov 14, 2017
BUY
$5.85 - $6.2 $836 - $886
143 Added 1.26%
11,460 $71,000
Q2 2017

Aug 14, 2017
BUY
N/A
2,017 Added 21.69%
11,317 $68,000
Q1 2017

Nov 14, 2017
BUY
N/A
9,300
9,300 $49,000

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email